Comparison 16. combined regimen methotrexate/prostaglandin: timing of prostaglandin.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 failure to achieve complete abortion | 3 | Risk Ratio (M‐H, Fixed, 95% CI) | Subtotals only | |
1.1 misoprostol day 7 vs day 3 | 1 | 86 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.14 [0.02, 1.10] |
1.2 misoprostol day 5 vs day 3 | 2 | 387 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.72 [0.36, 1.43] |
1.3 misoprostol day 5 vs day 4 | 2 | 394 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.74 [0.37, 1.48] |
1.4 misoprostol day 4 vs day 3 | 2 | 393 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.97 [0.52, 1.80] |